Home > Clinical Trials
Check All Search

Saved trials

Completed
NCT01857622
Safety and Pharmacokinetics Study of DU-176b Administered to Non-valvular Atrial Fibrillation With Severe Renal Impairment
93 Enrollment(s)
1 Study location(s)
Interventional (Phase III)
Non-valvular Atrial Fibrillation
Completed
NCT01857583
Safety and Pharmacokinetics Study of DU-176b Administered to Patients With Severe Renal Impairment Undergoing Orthopedic Surgery of The Lower Limbs
80 Enrollment(s)
1 Study location(s)
Interventional (Phase III)
Venous Thromboembolism
Completed
NCT01181167
A Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty
610 Enrollment(s)
0 Study location(s)
Interventional (Phase III)
Prevention
Venous Thromboembolism
Completed
NCT01181141
Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Hip Fracture Surgery
92 Enrollment(s)
0 Study location(s)
Interventional (Phase III)
Venous Thromboembolism
Completed
NCT01181102
A Phase 3 Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Knee Arthroplasty
716 Enrollment(s)
0 Study location(s)
Interventional (Phase III)
Venous Thromboembolism
Completed
NCT00986154
Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study).
8,292 Enrollment(s)
407 Study location(s)
Interventional (Phase III)
Venous Thromboembolism
Deep Vein Thrombosis (DVT)
Pulmonary Embolism (PE)
Thromboembolism
Venous Thrombosis
Completed
NCT00781391
Global Study to Assess the Safety and Effectiveness of Edoxaban (DU-176b) vs Standard Practice of Dosing With Warfarin in Patients With Atrial Fibrillation
21,105 Enrollment(s)
0 Study location(s)
Interventional (Phase III)
Stroke
Atrial Fibrillation
Embolism
Completed
NCT03254147
Medical Need of OAC Reversal
53,969 Enrollment(s)
1 Study location(s)
Observational
Atrial Fibrillation